Published in J Clin Oncol on February 01, 1996
A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. Blood (2007) 2.19
Status of minimal residual disease testing in childhood haematological malignancies. Br J Haematol (2008) 1.43
Flow cytometric chemosensitivity assay as a predictive tool of early clinical response in acute lymphoblastic leukemia. Pediatr Blood Cancer (2009) 1.42
A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome. Blood (2006) 1.40
Cytoreduction and prognosis in childhood acute lymphoblastic leukemia. J Clin Oncol (1996) 1.18
Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia. Haematologica (2012) 1.17
Hematopoietic stem cell transplantation for leukemia. Pediatr Clin North Am (2010) 0.90
Bridging the gap between the north and south of the world: the case of treatment response in childhood acute lymphoblastic leukemia. Haematologica (2009) 0.87
Early Response to Dexamethasone as Prognostic Factor: Result from Indonesian Childhood WK-ALL Protocol in Yogyakarta. J Oncol (2012) 0.78
Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China. BMC Pediatr (2015) 0.78
Cytoreduction and prognosis in childhood acute lymphoblastic leukemia. J Clin Oncol (1997) 0.76
Therapeutic trials in childhood ALL: what's their future? J Clin Pathol (2000) 0.75
Methods of the International Tobacco Control (ITC) Four Country Survey. Tob Control (2006) 11.36
In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst (1973) 11.26
The conceptual framework of the International Tobacco Control (ITC) Policy Evaluation Project. Tob Control (2006) 10.62
BCG in the treatment of acute lymphocytic leukemia. Blood (1975) 9.88
Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med (1985) 7.79
Sequential designs for phase I clinical trials with late-onset toxicities. Biometrics (2000) 5.50
The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol (1995) 5.36
Impact of graphic and text warnings on cigarette packs: findings from four countries over five years. Tob Control (2009) 4.60
Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. N Engl J Med (1998) 4.39
The Intergroup Rhabdomyosarcoma Study-I. A final report. Cancer (1988) 3.29
Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. Blood (1998) 3.24
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study. Leukemia (2008) 3.10
Socioeconomic and country variations in knowledge of health risks of tobacco smoking and toxic constituents of smoke: results from the 2002 International Tobacco Control (ITC) Four Country Survey. Tob Control (2006) 3.07
Effects of the 2003 advertising/promotion ban in the United Kingdom on awareness of tobacco marketing: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control (2006) 3.05
Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys (2001) 2.94
Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J Clin Invest (1983) 2.91
The Intergroup Rhabdomyosarcoma Study-II. Cancer (1993) 2.77
Inducible plasmid-determined resistance to arsenate, arsenite, and antimony (III) in escherichia coli and Staphylococcus aureus. J Bacteriol (1981) 2.70
Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report. Leukemia (2009) 2.58
A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage. J Immunol (1981) 2.52
Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol (2000) 2.51
Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia (2000) 2.48
Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG. Int J Radiat Oncol Biol Phys (2001) 2.44
Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics. Blood (1985) 2.35
Combination chemotherapy in refractory immune thrombocytopenic purpura. N Engl J Med (1993) 2.33
Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease. Bone Marrow Transplant (1996) 2.29
Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: identification of 11q23 translocation breakpoints with a yeast artificial chromosome. Proc Natl Acad Sci U S A (1990) 2.29
Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med (1991) 2.27
A comparison of four staging systems for localized and regional neuroblastoma: a report from the Childrens Cancer Study Group. J Clin Oncol (1990) 2.26
Current trends in breast reduction. Plast Reconstr Surg (1999) 2.24
Multiple sclerosis in mothers of children with acute lymphoblastic leukemia. Leukemia (1989) 2.20
Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood (1996) 2.19
Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. J Clin Oncol (1999) 2.14
What happened to smokers' beliefs about light cigarettes when "light/mild" brand descriptors were banned in the UK? Findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control (2008) 2.09
The continual reassessment method for multiple toxicity grades: a Bayesian quasi-likelihood approach. Biometrics (2007) 2.07
Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma. J Pediatr (1994) 2.06
Intrathecal leucovorin after intrathecal methotrexate overdose. J Pediatr Hematol Oncol (1996) 2.06
The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys (1995) 2.05
The clinical pharmacology of methotrexate: new applications of an old drug. Cancer (1978) 2.05
Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys (2001) 1.98
Mitogenic properties of a calcium ionophore, A23187. Proc Natl Acad Sci U S A (1974) 1.98
Fate of bacteriophage lambda in non-immune germ-free mice. Nature (1973) 1.96
Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med (1980) 1.95
Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. J Clin Oncol (1995) 1.94
The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. J Neurooncol (1989) 1.92
Self-reported health and survival in the Longitudinal Study of Aging, 1984-1986. J Clin Epidemiol (1995) 1.89
Home care for children dying of cancer. Pediatrics (1978) 1.88
Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992. J Pediatr Hematol Oncol (1997) 1.87
Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia. J Clin Oncol (1999) 1.87
Prevalence and attributes of roll-your-own smokers in the International Tobacco Control (ITC) Four Country Survey. Tob Control (2006) 1.84
Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis. J Pediatr (1996) 1.84
A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys (1996) 1.83
Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). N Engl J Med (1983) 1.82
P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody. J Exp Med (1981) 1.79
Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med (1988) 1.77
Epidemiological characteristics of childhood acute lymphocytic leukemia. Analysis by immunophenotype. The Childrens Cancer Group. Leukemia (1994) 1.76
The development of hemostasis in the human fetus and newborn infant. J Pediatr (1971) 1.75
Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc Natl Acad Sci U S A (1993) 1.73
Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood (1988) 1.72
Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Oncol Biol Phys (1994) 1.68
Tissue examination to monitor antiangiogenic therapy: a phase I clinical trial with endostatin. Clin Cancer Res (2001) 1.66
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia (2003) 1.64
Neurologic sequelae of methotrexate and ionizing radiation: a new classification. Cancer Treat Rep (1981) 1.62
Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse. Blood (2001) 1.61
Tracking of airborne radionuclides from the damaged Fukushima Dai-ichi nuclear reactors by European networks. Environ Sci Technol (2011) 1.61
beta-Lactamase activity in human pus. J Infect Dis (1980) 1.57
Parents' perceptions of randomization in pediatric clinical trials. Children Cancer Group. Cancer Pract (2000) 1.56
Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol (2000) 1.56
Ewing's sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991. J Clin Oncol (1997) 1.54
A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2001) 1.54
Antibody affinity may influence antigenic modulation of the common acute lymphoblastic leukemia antigen in vitro. J Immunol (1982) 1.53
Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood (1992) 1.53
Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia. Int J Radiat Oncol Biol Phys (1995) 1.53
Recurrent nasopharyngeal carcinoma: the puzzles of long latency. Int J Radiat Oncol Biol Phys (1999) 1.52
Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse--the Children's Cancer Group Experience. Cancer (1998) 1.49
Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial. J Clin Oncol (1993) 1.49
Methotrexate: clinical pharmacology, current status and therapeutic guidelines. Cancer Treat Rev (1977) 1.46
Identification of novel B-lineage cells in human fetal bone marrow that coexpress CD7. Blood (1991) 1.46
Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. J Clin Oncol (1994) 1.45
Acute lymphoblastic leukemic cells with T (thymus-derived) lymphocyte markers. Science (1973) 1.45
The management of cancer in the older adolescent. Eur J Cancer (2003) 1.45
Smokers' reactions to reduced ignition propensity cigarettes. Tob Control (2006) 1.44
Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol (1999) 1.44